Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.490
-0.020 (-0.80%)
At close: Feb 5, 2026
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 928.05 million as of February 5, 2026. Its market cap has decreased by -14.22% in one year.
Market Cap
928.05M
Enterprise Value
1.46B
Revenue
627.22M
Ranking
n/a
PE Ratio
165.31
Stock Price
2.49
Market Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 928.05M, an increase of 251.84%. That is a compound annual growth rate of 12.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 935.51M | -1.18% |
| Dec 31, 2025 | 946.69M | -12.49% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 11.15B |
| Healius | 682.56M |
| Australian Clinical Labs | 511.60M |
| Monash IVF Group | 274.69M |
| Rhythm Biosciences | 57.24M |
| Cryosite | 53.69M |
| Microba Life Sciences | 52.37M |
| INOVIQ | 47.86M |